Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 945,649 |
|
|||||
| News | - | ||||||
| Day High | 39.33 | Low High |
|||||
| Day Low | 36.26 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Apogee Therapeutics Inc | APGE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -2.62 | -6.72% | 36.37 | 00:00:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 39.13 | 36.26 | 39.33 | 36.37 | 38.99 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,460 | 945,649 | $ 37.32 | $ 35,288,776 | - | 14.19 - 72.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:29:26 | 5 | $ 36.50 | USD |
Apogee Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.85B | 50.66M | - | 0 | -83.99M | -1.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Apogee Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APGE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 43.39 | 45.97 | 36.26 | 41.70 | 348,992 | -7.02 | -16.18% |
| 1 Month | 51.94 | 52.07 | 36.26 | 44.57 | 374,425 | -15.57 | -29.98% |
| 3 Months | 64.20 | 69.40 | 36.26 | 52.09 | 429,193 | -27.83 | -43.35% |
| 6 Months | 22.87 | 72.29 | 22.20 | 51.45 | 530,459 | 13.50 | 59.03% |
| 1 Year | 21.50 | 72.29 | 14.19 | 40.42 | 438,214 | 14.87 | 69.16% |
| 3 Years | 21.50 | 72.29 | 14.19 | 40.42 | 438,214 | 14.87 | 69.16% |
| 5 Years | 21.50 | 72.29 | 14.19 | 40.42 | 438,214 | 14.87 | 69.16% |
Apogee Therapeutics Description
| Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. |
